
Jens Lehmann
@jlehmann_ibk
early career investigator @imed_tweets | current chair of ECI group at @EORTC_QLG & EORTC board member
patient-reported outcomes | ePRO | cancer |
ID: 1186559877092646912
https://orcid.org/my-orcid?orcid=0000-0002-4670-7517 22-10-2019 08:28:42
495 Tweet
298 Followers
543 Following




🎯Glad to share our npj Journals Breast Cancer publication on ML-based spatial characterization of #TumorMicroenvironment in early #breastcancer in the EORTC Breast Cancer Group 10994/BIG 1-00 trial shorturl.at/nwYU6 Thanks to all collaborators! EORTC OncoAlert Michail ignatiadis Theodoros Foukakis



Exploring the integration of patient-reported outcome measures in clinical practice Jens Lehmann Ryan Nipp, MD, MPH, MBA, FASCO oncodaily.com/blog/clinical-… #Cancer #CancerResearch #Medicine #Health #MedX #MedNews #MedEd #ClinicalPractice #Oncology #OncoDaily





On #ClinicalTrialsDay, meet the next generation driving #CancerResearch forward. In this video, Ioannis Zerdes, Jens Lehmann, and Antonella Cammarota share what it means to be part of the EORTC Early Career Investigator community. Learn more: eortc.org/blog/2025/05/2…


🔁 Important read! New commentary by Eva Gamper et al. in The Lancet Oncology explores why cancer-specific #QualityofLife tools matter in economic evaluations. A timely discussion in the context of the recent EU HTA reform. 📝 Read more: eortc.org/blog/2025/05/1… #GivingVoice2Patients


📢Excited to announce the election of Benjamin Besse as EORTC President-Elect, starting in June 2026, following WinetteVanDerGraaf 🙌 Also, we welcome the new chairs of the Scientific Chairs Council: Anne-Marie Dingemans and Jean-Pascal Machiels!🔬🎉 👉 eortc.org/blog/2025/06/2…
